000 | 01386 a2200373 4500 | ||
---|---|---|---|
005 | 20250513075012.0 | ||
264 | 0 | _c19930923 | |
008 | 199309s 0 0 eng d | ||
022 | _a0077-8923 | ||
024 | 7 |
_a10.1111/j.1749-6632.1993.tb22916.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSher, E | |
245 | 0 | 0 |
_aNeuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies. _h[electronic resource] |
260 |
_bAnnals of the New York Academy of Sciences _cJun 1993 |
||
300 |
_a373-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aAutoantibodies _ximmunology |
650 | 0 | 4 |
_aCalcium Channels _xdrug effects |
650 | 0 | 4 |
_aCarcinoma, Small Cell _ximmunology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLambert-Eaton Myasthenic Syndrome _ximmunology |
650 | 0 | 4 |
_aLung Neoplasms _ximmunology |
650 | 0 | 4 |
_aNerve Tissue Proteins _xphysiology |
650 | 0 | 4 |
_aNeurons _ximmunology |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 | _aomega-Conotoxin GVIA |
700 | 1 | _aCarbone, E | |
700 | 1 | _aClementi, F | |
773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 681 _gp. 373-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1993.tb22916.x _zAvailable from publisher's website |
999 |
_c8394423 _d8394423 |